Atlas Trials

4SC AG

13 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch 4SC AG

RecordFirmDate
Domatinostat in Combination With Avelumab in Patients With Treatment-naïve Metastatic Merkel Cell Carcinoma (MERKLIN 1) (NCT04874831)4SC AG2021-11-01
A Phase 1, Open-label Study of the Absorption, Metabolism, Excretion of [14C]-Resminostat (NCT04955340)4SC AG2021-10-12
Domatinostat in Combination With Avelumab in Patients With Advanced Merkel Cell Carcinoma Progressing on Anti-PD-(L)1 (NCT04393753)4SC AG2020-10-13
4SC-202 in Combination With Pembrolizumab in Patients Primary Refractory/Non-responding to Prior Anti-PD-1 Therapy (NCT03278665)4SC AG2017-09-25

Track 4SC AG automatically

Every clearance here is in the API, with alerts when new ones post.